EXECUTIVE ENGAGEMENTS
POOL
373
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
73
Interactions with Platform & by Email
PARTICIPANTS
13
Unique # Participated
VALIDATIONS
6
Responses Validated*
COMPANIES
11
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
179
EDITION
9
PRICE
USD 4950
CODE
MCP11238
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Computational Biology estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at a CAGR of 19.2% over the analysis period 2020-2027. Cellular & Biological Simulation, one of the segments analyzed in the report, is projected to record a 18.1% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery & Disease Modelling segment is readjusted to a revised 18.9% CAGR for the next 7-year period.
The Computational Biology market in the U.S. is estimated at US$798.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 18.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.6% and 16.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14% CAGR.
In the global Preclinical Drug Development segment, USA, Canada, Japan, China and Europe will drive the 23.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$149.5 Million in the year 2020 will reach a projected size of US$650.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.1 Billion by the year 2027.
SELECT PLAYERS
Certara LP; Chemical Computing Group ULC; Compugen Ltd.; Dassault Systemes; Genedata AG; Insilico Biotechnology AG; Leadscope, Inc.; Nimbus Therapeutics; Rosa & Co. LLC; Schrodinger LLC; Simulations Plus, Inc.; Strand Life Sciences Pvt., Ltd.
SEGMENTS
» Application Area (Cellular & Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software) » End-Use (Academics, Industry, Commercial) » Service (In-House Services, Contract Services)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Computational Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Cellular & Biological Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Cellular & Biological Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Drug Discovery & Disease Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Drug Discovery & Disease Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Preclinical Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Preclinical Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Human Body Simulation Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Human Body Simulation Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Contract Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Contract Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| USA Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| USA Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| China Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| China Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Computational Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| France Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| France Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| UK Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| UK Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Computational Biology by Application Area - Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Computational Biology by Application Area - Percentage Breakdown of Value Sales for Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials and Human Body Simulation Software for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Computational Biology by Service - In-House Services and Contract Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for In-House Services and Contract Services for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Computational Biology by End-Use - Academics, Industry and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Academics, Industry and Commercial for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 11 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com